The future of medicine is based on intensive research. Innovations from genetic research and digitization, for example, are revolutionizing medicine and healthcare more than ever before. Strong entrepreneurs are also needed to turn scientists’ results into real products and help to improve patients’ diagnosis, prevention, therapy, nursing and rehabilitation. These stories provide insights into the top research and development in central Hessen and show the latest trends – always for the benefit of patients all over the world.
In the search for medicines to treat COVID-19, lung researchers from Giessen are testing an existing active ingredient that has already been proven to prevent lung damage.
Insect research is a Giessen success story: Experts expect innovative solutions for global challenges. The State of Hessen is now providing further funding for the region’s scientific efforts.
The new MacTRAP mouse line allows researchers to closely study ‘hidden’ renal macrophages. These results open up new possibilities for the diagnosis of inflammatory diseases.
Die Deutsche Forschungsgemeinschaft (DFG) unterstützt mit 13,84 Millionen Euro ein Forschungskonsortium aus Mittelhessen, das nach neuen Strategien zur Behandlung von tödlichen und bislang unheilbaren Lungenhochdruck sucht.
Marburg-based pharmaceutical company CSL Behring is conducting intensive research on a suitable active substance against Covid-19 with the use of donated blood plasma. A globally active “Plasma Alliance” established for this purpose supports the company’s goals.
The fight against SARS-CoV-2 can be conducted on different levels. Alcedis is currently participating in three clinical studies on coronavirus infection.
Good medicine needs secure financing: The medService of Volksbank Mittelhessen offers doctors, pharmacies and clinics tailor-made financing for investments, devices and office equipment.
Giessen dermatologist and professor Dr. Peter Mayser has succeeded in developing a natural anti-dandruff agent in collaboration with Symrise AG, which is being marketed under the name Crinipan® PMC green.